Avrobio Secures $25,000,000 Series A Round

  • Feed Type
  • Date
    8/3/2016
  • Company Name
    Avrobio
  • Mailing Address
    400 Technology Square 10th Floor Cambridge, MA 02139 USA
  • Company Description
    AVROBIO is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. The catalyst for creating AVROBIO is to accelerate scientific breakthroughs related to the convergence of cell and gene therapies.
  • Website
    http://www.avrobio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    AVROBIO will use the proceeds from this financing to accelerate development of its clinical stage programs in Fabry disease and acute myeloid leukemia (AML), and to expand its pipeline in rare diseases and solid and liquid cancers.
  • M&A Terms
  • Venture Investor
    Atlas Accelerator
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Undisclosed

Trending on Xconomy